razoxane has been researched along with sobuzoxane in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andoh, T; Ikegami, Y; Ishida, R; Tanabe, K | 1 |
| Hoshino, A; Inaba, M; Komatsu, T; Narita, T; Takase, M; Tsukagoshi, S; Yaguchi, S | 1 |
| Azuma, Y; Kizaki, H; Onishi, Y | 1 |
| Furue, H | 1 |
| Maehara, Y; Sugimachi, K; Yoshida, M | 1 |
| Ding, J; Hu, CX; Huang, M; Li, MH; Lin, LP; Lu, DY; Lu, W; Tong, LJ; Xu, CH; Yang, WY; Zhang, XW | 1 |
| Ding, J; Huang, M; Lu, DY; Xu, B; Xu, CH; Zhu, H | 1 |
| Lu, DY; Lu, TR | 2 |
| Jirkovská, A; Karabanovich, G; Piskáčková, HB; Reimerová, P; Roh, J; Šimůnek, T; Štěrbová-Kovaříková, P | 1 |
3 review(s) available for razoxane and sobuzoxane
| Article | Year |
|---|---|
[Topoisomerase inhibitors developing in Japan].
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzopyrans; Camptothecin; Diketopiperazines; Glycosides; Humans; Irinotecan; Neoplasms; Phenazines; Piperazines; Razoxane; Topotecan | 1993 |
Anticancer activities and mechanisms of bisdioxopiperazine compounds probimane and MST-16.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Humans; Mice; Mice, Inbred C57BL; Piperazines; Razoxane | 2010 |
Antimetastatic activities and mechanisms of bisdioxopiperazine compounds.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Transformed; Fibrinogen; Humans; Mice; Molecular Targeted Therapy; Neoplasm Metastasis; Piperazines; Razoxane | 2010 |
7 other study(ies) available for razoxane and sobuzoxane
| Article | Year |
|---|---|
Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.
Topics: Antineoplastic Agents; Diketopiperazines; DNA; Piperazines; Razoxane; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1991 |
Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Leukemia P388; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Piperazines; Razoxane; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
bis(2,6-dioxopiperaxine) derivatives, topoisomerase II inhibitors which do not form a DNA cleavable complex, induce thymocyte apoptosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cells, Cultured; Cycloheximide; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Nucleic Acid Conformation; Piperazines; Razoxane; Thymus Gland; Topoisomerase I Inhibitors | 1994 |
MST-16, a novel bis-dioxopiperazine anticancer agent, ameliorates doxorubicin-induced acute toxicity while maintaining antitumor efficacy.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Digestive System; Doxorubicin; Female; Humans; Lethal Dose 50; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Piperazines; Prodrugs; Razoxane; Survival Analysis; Tumor Cells, Cultured | 1999 |
Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.
Topics: Antineoplastic Agents; Chromosome Segregation; G2 Phase; Humans; Piperazines; Razoxane; Tumor Cells, Cultured | 2005 |
Medicinal chemistry of probimane and MST-16: comparison of anticancer effects between bisdioxopiperazines.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Mice; Mice, Nude; Molecular Structure; Piperazines; Razoxane; Structure-Activity Relationship; Time Factors; Xenograft Model Antitumor Assays | 2006 |
UHPLC-MS/MS method for analysis of sobuzoxane, its active form ICRF-154 and metabolite EDTA-diamide and its application to bioactivation study.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chromatography, High Pressure Liquid; Edetic Acid; Myocytes, Cardiac; Piperazines; Rats; Rats, Wistar; Razoxane; Tandem Mass Spectrometry | 2019 |